Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CAR-T
CAR-T
WMIF panel: How cell and gene therapy can overcome limitations of CAR T
MedCity News
Tue, 05/3/22 - 10:35 am
CAR-T
cell therapy
gene therapy
solid tumors
World Medical Innovation Forum
Astellas, Tmunity, Underscore Rocky Terrain of CAR-T and Gene Therapies
BioSpace
Mon, 04/25/22 - 10:38 pm
Astellas
Tmunity
CAR-T
gene therapy
myotubular myopathy
Study: Black patients underrepresented in pivotal CAR T-cell trials
RAPS.org
Thu, 04/21/22 - 11:20 pm
CAR-T
clinical trials
clinical trial diversity
Legend Biotech Achieves Milestone Under Collaboration Agreement with Janssen Biotech, Inc. for BCMA CAR-T
BioSpace
Thu, 04/21/22 - 10:57 am
Legend Biotech
Janssen
Carvykti
cilta-cel
CAR-T
Kite’s Maryland CAR T-cell therapy site gets FDA go-ahead
Biopharma Reporter
Wed, 04/20/22 - 10:43 am
Kite Pharma
Gilead Sciences
FDA
CAR-T
drug manufacturing
Yescarta
AACR22: As post-Covid development takes shape, BioNTech reports first human data for CAR-T/cancer vaccine combo
Endpoints
Sun, 04/10/22 - 07:49 pm
AACR
BioNTech
clinical trials
CAR-T
MRNA
testicular cancer
ovarian cancer
2 Biotechs With Recent FDA Approvals to Hold for the Next Decade
Motley Fool
Wed, 04/6/22 - 12:24 pm
Legend Biotech
CAR-T
Immunocore
TCR immunotherapy
FDA releases draft guidance for cell and gene therapies
Biopharma Reporter
Wed, 04/6/22 - 11:35 am
FDA
regulatory
cell therapy
gene therapy
CAR-T
Gilead beats BMS to FDA okay for early lymphoma CAR-T therapy
Pharmaforum
Mon, 04/4/22 - 10:18 am
Gilead Sciences
Kite Pharma
CAR-T
Bristol Myers Squibb
lymphoma
large B-cell lymphoma
FDA quickly follows a voluntary pause for CAR-T 2.0 with a clinical hold to investigate 2 patient deaths
Endpoints
Wed, 03/2/22 - 10:28 am
Celyad
FDA
patient deaths
CAR-T
clinical holds
J&J, Legend cell therapy approved by FDA for multiple myeloma
BioPharma Dive
Mon, 02/28/22 - 11:44 pm
JNJ
Legend Biotech
FDA
Multiple Myeloma
Carvykti
CAR-T
Deaths in Keytruda combo study spur Celyad to pause trial of off-the-shelf CAR-T cell therapy
Fierce Biotech
Mon, 02/28/22 - 11:24 am
Celyad Oncology
CAR-T
clinical trials
Keytruda
CYAD-101
colorectal cancer
'Major blunder:' Ex-staffers blast Bristol Myers Squibb's handling of Breyanzi approval in latest CVR lawsuit update
Fierce Pharma
Wed, 02/23/22 - 10:09 pm
Bristol Myers Squibb
legal
Breyanzi
shareholders
CAR-T
liso-cel
lymphoma
Atara, Memorial Sloan Kettering investigating patient death in phase 1 mesothelioma CAR-T study
Fierce Biotech
Sun, 02/20/22 - 11:46 am
Atara Biotherapeutics
clinical trials
mesothelioma
CAR-T
patient deaths
Legend's early-stage CAR-T on FDA hold after single patient dosed
Fierce Biotech
Tue, 02/15/22 - 10:15 am
Legend Biotech
CAR-T
FDA
clinical trials
clinical hold
LB1901
Arcellx’s IPO raises $124M to fuel chase of better CAR T-cell therapy for cancer
MedCity News
Tue, 02/8/22 - 09:53 am
Arcellx
IPOs
CAR-T
funding
cell therapy
Multiple Myeloma
Bristol busy boosting supply of Breyanzi, Abecma as massive Revlimid patent cliff looms
Fierce Pharma
Fri, 02/4/22 - 11:22 am
Bristol Myers Squibb
CAR-T
Breyanzi
Abecma
What's Behind Bristol Myers Squibb's Latest Partnership?
Motley Fool
Sat, 01/22/22 - 02:17 pm
Bristol Myers Squibb
Century Therapeutics
CAR-T
cancer
As Abecma sales take off, Bristol Myers and 2seventy scrap a follow-up CAR-T
Endpoints
Thu, 01/13/22 - 07:21 am
Bristol Myers Squibb
2seventy bio
Abecma
bb21217
CAR-T
A late Christmas present for Allogene
EP Vantage
Mon, 01/10/22 - 11:27 am
Allogene
JPMHC 2022
FDA
CAR-T
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »